Provided by Tiger Trade Technology Pte. Ltd.

FOSUN PHARMA

15.990
-0.510-3.09%
Volume:5.74M
Turnover:91.72M
Market Cap:42.52B
PE:10.80
High:16.480
Open:16.480
Low:15.800
Close:16.500
52wk High:28.232
52wk Low:14.505
Shares:2.66B
HK Float Shares:540.97M
Volume Ratio:0.99
T/O Rate:1.06%
Dividend:0.45
Dividend Rate:2.84%
EPS(LYR):1.481
ROE:6.95%
ROA:1.40%
PB:0.75
PE(LYR):10.80
PS:0.86

Loading ...

Fosun Pharmaceutical to Invest 414 Million Yuan in Xingyao Kunze's Series B Funding Round

MT Newswires Live
·
May 27

Fosun Pharma Gets Registration Nod for Infection Drug in China

MT Newswires Live
·
May 21

Fosun Pharma receives NMPA clearance for Yaopharma-developed Levofloxacin Injection

Bulletin Express
·
May 21

FOSUN PHARMA Subsidiary Gains Approval for Levofloxacin Injection

Stock News
·
May 21

Shanghai Fosun Pharma - Drug Registration Application for Levofloxacin Injection Approved by China's Nmpa

THOMSON REUTERS
·
May 21

FOSUN PHARMA Subsidiary's HLX3902 Injection Approved for Clinical Trials in Australia

Stock News
·
May 21

Sinopharm Group Stock Sheds 1.2% in Hong Kong

Dow Jones
·
May 21

Sinopharm Group Stock Falls 2.1% in Hong Kong

Dow Jones
·
May 18

FOSUN PHARMA's Strategic Move: $60 Million Secures Potential Over $2.5 Billion for AR1001

Stock News
·
May 14

Fosun Pharma Secures $60 Million Option for Alzheimer's Drug

MT Newswires Live
·
May 14

China's AI Power Consumption Set to Soar, Spotlight on Computing-Power Synergy

Stock News
·
May 14

Fosun Pharma's Unit's Registration Application for Blood Stasis Syndrome Drug Accepted in China

MT Newswires Live
·
May 13

Fosun Pharma Subsidiary’s Tao Hong Si Wu Tang Granules Secures NMPA Filing Acceptance

Bulletin Express
·
May 13

FOSUN PHARMA's Application for Traditional Chinese Medicine New Drug Accepted for Review

Stock News
·
May 13

Shanghai Fosun Pharma - Drug Registration Applications of Tao Hong Si Wu Tang Granules by Unit Accepted by Nmpa China

THOMSON REUTERS
·
May 13

Fosun Pharma Releases 2026 AGM & Second H-Shareholders Meeting Circular; Offers Digital Access and Print Options

Bulletin Express
·
May 11

Fosun Pharma Calls 16 June 2026 H Shareholders Meeting to Seek 10% Dual-Class Buyback Mandates

Bulletin Express
·
May 11

Fosun Pharma Calls 16 June AGM to Vote on RMB0.39 Dividend, RMB35 Billion Guarantee Cap and New Financing Mandates

Bulletin Express
·
May 11

Fosun Pharma's Unit Gets Nod for Registration of Venlafaxine Hydrochloride Tablets

MT Newswires Live
·
May 11

Henlius Biotech Gets European Commission's Nod for Hetronifly

MT Newswires Live
·
May 11